Oxford Science Enterprises
About Oxford Science Enterprises
Oxford Science Enterprises (OSE) is an independent investment company and venture builder powered by a partnership with the University of Oxford. It transforms cutting-edge Oxford science into companies, focusing on Deep Tech, Life Sciences, and HealthTech to solve major global challenges while delivering strong returns for investors. Based in Oxford, United Kingdom, OSE collaborates with researchers, entrepreneurs, and global co-investors to find bold ideas, fund them with patient capital, and build world-changing ventures. The organization highlights its portfolio of flagship companies and a multi-billion-pound pipeline developed over a decade of venture-building excellence.
Recent News
Former ARIA Exec Joins Oxford Science Enterprises
GV-Backed Biotech Startup OMass Faces IP Lawsuit
Quantum Motion Secures $160M Series C to Scale Silicon Spin QPUs
Archangel Lightworks Completes Successful Trials for Miniature Deployable Optical Ground Station
Oxford-Based Caudal Energy Lands €4.9 Million to Develop Predictable Renewable Power From Tidal Flow
Archangel Lightworks Secures £10M Series A to Scale Optical Ground Infrastructure
Stateful Robotics Secures $4.8M to Advance Long-Term Robot Intelligence
Anthropic in Early Talks to Buy DRAM-Less AI Inference Chips From UK Startup — Fractile's SRAM Architecture Reduces Need for Pricey Memory During Extreme Pricing and Shortage Crunch
Quantum Motion Secures $160 Million Series C to Scale Silicon Spin Qubits
Wild Bioscience Expands Milton Park Operations
Inside Oxford’s Biotech Hub: A Scientific Powerhouse Situated in the U.K.’s Golden Triangle
Lansdowne Partners Raises €128.9 Million ($150 Million) for UK University IP Fund
Almost 80 European Deep Tech University Spinouts Reached $1B Valuations or $100M in Revenue in 2025
UK Tech Funding Roundup: This Week’s Deals From Quantum Motion to Lunar